PHENIDIN 36 MG

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Kúpte ho teraz

Príbalový leták Príbalový leták (PIL)
18-10-2023

Aktívna zložka:

METHYLPHENIDATE HYDROCHLORIDE

Dostupné z:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

ATC kód:

N06BA04

Forma lieku:

TABLETS PROLONGED RELEASE

Zloženie:

METHYLPHENIDATE HYDROCHLORIDE 36 MG

Spôsob podávania:

PER OS

Typ predpisu:

Required

Výrobca:

DEVELCO PHARMA GMBH, GERMANY

Terapeutické oblasti:

METHYLPHENIDATE

Terapeutické indikácie:

For the treatment of attention deficit hyperactivity disorder (ADHD).

Dátum Autorizácia:

2023-11-30

Príbalový leták

                                Patient leaflet in accordance with the Pharmacists’
Regulations (Preparations) - 1986
This medicine is dispensed with a doctor’s prescription only
Phenidin
prolonged-release tablets
Each Phenidin 18 mg tablet contains:
methylphenidate hydrochloride 18 mg.
Each Phenidin 27 mg tablet contains:
methylphenidate hydrochloride 27 mg.
Each Phenidin 36 mg tablet contains:
methylphenidate hydrochloride 36 mg.
Each Phenidin 54 mg tablet contains:
methylphenidate hydrochloride 54 mg.
Inactive ingredients and allergens in this medicine – See section 2
under ‘Important information about some of this medicine’s
ingredients’
and section 6 – ‘Additional information’.
Read the entire leaflet carefully before you start using this
medicine.
This
leaflet
contains
concise
information
about
this
medicine. If you have any further questions, consult your doctor or
pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others.
It may harm them, even if it seems to you that their medical condition
is similar to yours.
1. What is this medicine intended for?
Phenidin is intended for the treatment of attention deficit
hyperactivity
disorder (ADHD) in children over 6 years old, adolescents, and adults
up to 65 years old.
Phenidin
can
improve
attention
and
concentration
and
reduce
impulsivity and hyperactivity in people with ADHD.
Phenidin should be given as part of an ADHD treatment program that
may include counselling or other therapy.
Therapeutic group: central nervous system stimulant.
2. Before using this medicine
Do not use this medicine if:
you are sensitive (allergic) to the active ingredient (methylphenidate
hydrochloride) or to any of the other ingredients in this medicine
(see section 6 ‘Additional information’)
you are experiencing marked anxiety, mental tension, or agitation
you have an eye problem called glaucoma (increased intraocular
pressure)
you have tics or Tourette’s syndrome, or a family history of
Tourette’s syndrome. Tics are repetitive movements or sounds that
you cannot co
                                
                                Prečítajte si celý dokument
                                
                            

Dokumenty v iných jazykoch

Príbalový leták Príbalový leták arabčina 18-10-2023
Príbalový leták Príbalový leták hebrejčina 19-10-2023

Vyhľadávajte upozornenia súvisiace s týmto produktom

Zobraziť históriu dokumentov